Analyzing the link between obesity and arrhythmia, LEGACY confirmed that among obese patients, weight loss greatly influenced freedom from atrial fibrillation, particularly among those who lost weight and maintained it.
For patients with ACS who are unable to swallow whole tablets, ticagrelor is now approved by the FDA to be crushed and administered in water by swallowing or via nasogastric tube, according to an announcement from AstraZeneca.
A cardiovascular disease risk equation that can be adjusted to apply to any country with adequate health records, regardless of income level, has been developed, according to Dr. Kaveh Hajifathalian of the Harvard School of Public Health, Boston, and associates.
The names of young specialists who will receive grants to participate in the International school on epidemiology and prevention on May 23rd, 2015 are already known.
In patients with atrial fibrillation, researchers found no significant class effect for direct thrombin inhibitors or factor Xa inhibitors, according to meta-analysis results.
Uric acid levels in patients with symptomatic heart failure and hyperuricemia were successfully lowered with prednisone treatment, and renal response to diuretics was improved, according to study findings.
Данный сайт и вся информация на нём предназначена для медицинских работников.
Продолжая просмотр, вы соглашаетесь и подтверждаете, что являетесь медицинским работником.